This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
World Health Organization. Depression. WHO website [online], (2011).
Belmaker, R. H. et al. Major depressive disorder. N. Engl. J. Med. 381, 55–68 (2008).
Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905–1917 (2006).
Kennedy, S. H. et al. Agomelatine in the treatment of major depressive disorder: potential for clinical effectiveness. CNS Drugs 24, 479–499 (2010).
Datamonitor. Market and Product Forecasts: Depression — Pipeline set to rejuvenate traditional classes. HC00076–003 (2011).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Chancellor, D. The depression market. Nat Rev Drug Discov 10, 809–810 (2011). https://doi.org/10.1038/nrd3585
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3585
This article is cited by
-
Meranzin Hydrate Improves Depression-Like Behaviors and Hypomotility via Ghrelin and Neurocircuitry
Chinese Journal of Integrative Medicine (2023)
-
nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story
Neuroscience Bulletin (2023)
-
Is the Chinese medicinal formula Guipi Decoction (归脾汤) effective as an adjunctive treatment for depression? A meta-analysis of randomized controlled trials
Chinese Journal of Integrative Medicine (2017)
-
Synthesis and antidepressant activity of 5-(benzo[b]furan-2-ylmethyl)-6-methylpyridazin-3(2H)-one derivatives
Medicinal Chemistry Research (2016)